Q517--Pharmacy Medication Compounding Contingency Service
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Michael E. Debakey VA Medical Center in Houston, TX, is seeking Emergency Contingency Services for Hazardous and Non-Hazardous Medication Compounding. This is a combined synopsis/solicitation issued as an RFQ (Request for Quote) for commercial products and services. The solicitation is unrestricted, and quotes are due by March 4, 2026, at 3:00 PM CST.
Scope of Work
The awarded contractor will provide emergency contingency services including:
- Aseptic compounding of hazardous and non-hazardous agents based on patient-specific orders.
- Provision of necessary items such as IV tubing, closed system drug transfer devices, and other supplies.
- Delivery of compounded orders to the Michael E. Debakey VA Medical Center by 7:30 AM the day after orders are submitted.
- Ensuring compounding, labeling, and beyond-use dating/expiration dating comply with USP 797, USP 800, and Federal Law.
- Providing current and future certification reports for sterile compounding areas and hoods.
- Updating and providing the "VHA PBM Assessment Guide for Compounded Sterile Preparations" at the time of response and annually.
- Meeting specific compatibility needs, including Bag Spike Rule (all chemo and Mabs), Primary IV Set (BD Secondary Set or interchangeable), Secondary IV Set (BD Secondary Set or interchangeable), and In-line Filter requirements.
Contract & Timeline
- Contract Type: Firm-fixed-price, Indefinite-Delivery-Indefinite-Quantity (IDIQ).
- Period of Performance: One year from the date of award.
- Set-Aside: Unrestricted.
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 Employees.
- PSC Code: Q517 (Pharmacy Services).
- Questions Due: February 25, 2026, by 3:00 PM CST.
- Quotes Due: March 4, 2026, by 3:00 PM CST.
- Published Date: February 23, 2026.
Evaluation
Award will be made on a Lowest Price Technically Acceptable (LPTA) basis. Evaluation factors include:
- Technical Factors: Offeror's Product (Brand Name or Equal), Contingency Plan, and Delivery Requirements.
- Price: Evaluated for reasonableness, completeness, and fairness.
Additional Notes
Offerors must complete annual representations and certifications electronically via the System for Award Management (SAM) website (https://sam.gov/). All questions and quotes must be submitted electronically via email to the Contract Specialist, Eugene Jackson, at Eugene.Jackson2@va.gov. FAR provisions and clauses are incorporated by reference, effective through FAC 2025-06 (eff. 08/27/2025).